R1 RCM Inc. (NASDAQ:RCM – Get Rating) – Equities researchers at SVB Leerink dropped their Q3 2022 earnings per share estimates for R1 RCM in a research report issued to clients and investors on Monday, May 9th. SVB Leerink analyst S. Davis now forecasts that the healthcare provider will earn $0.11 per share for the quarter, down from their prior estimate of $0.12. SVB Leerink also issued estimates for R1 RCM’s Q4 2022 earnings at $0.12 EPS, FY2022 earnings at $0.41 EPS and FY2023 earnings at $0.59 EPS.
R1 RCM (NASDAQ:RCM – Get Rating) last issued its quarterly earnings results on Monday, May 9th. The healthcare provider reported $0.09 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.10 by ($0.01). The business had revenue of $385.70 million for the quarter, compared to the consensus estimate of $384.18 million. R1 RCM had a return on equity of 29.44% and a net margin of 6.64%. R1 RCM’s revenue was up 12.6% on a year-over-year basis. During the same period in the prior year, the business posted ($2.37) earnings per share.
Shares of NASDAQ RCM opened at $22.52 on Thursday. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.06. The business has a fifty day simple moving average of $24.79 and a two-hundred day simple moving average of $24.49. The firm has a market cap of $6.30 billion, a PE ratio of 72.65, a price-to-earnings-growth ratio of 2.25 and a beta of 0.86. R1 RCM has a twelve month low of $18.71 and a twelve month high of $27.86.
A number of hedge funds have recently made changes to their positions in the stock. Advisor Group Holdings Inc. grew its stake in R1 RCM by 8.3% during the 3rd quarter. Advisor Group Holdings Inc. now owns 5,723 shares of the healthcare provider’s stock worth $128,000 after buying an additional 439 shares during the last quarter. Profund Advisors LLC grew its stake in R1 RCM by 4.3% during the 3rd quarter. Profund Advisors LLC now owns 11,671 shares of the healthcare provider’s stock worth $257,000 after buying an additional 485 shares during the last quarter. First Mercantile Trust Co. grew its stake in R1 RCM by 5.6% during the 3rd quarter. First Mercantile Trust Co. now owns 10,266 shares of the healthcare provider’s stock valued at $226,000 after purchasing an additional 544 shares during the last quarter. Prospera Financial Services Inc grew its stake in R1 RCM by 2.1% during the 1st quarter. Prospera Financial Services Inc now owns 27,760 shares of the healthcare provider’s stock valued at $743,000 after purchasing an additional 571 shares during the last quarter. Finally, Insight Wealth Strategies LLC grew its stake in R1 RCM by 0.6% during the 4th quarter. Insight Wealth Strategies LLC now owns 101,955 shares of the healthcare provider’s stock valued at $2,599,000 after purchasing an additional 636 shares during the last quarter. Hedge funds and other institutional investors own 41.97% of the company’s stock.
R1 RCM Company Profile (Get Rating)
R1 RCM Inc provides revenue cycle management (RCM) for healthcare providers in the United States. The company offers end-to-end RCM services to manage their revenue cycle operations that encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, bill preparation, and collections from patients and payers.
- Get a free copy of the StockNews.com research report on R1 RCM (RCM)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.